Reply by Authors
J Urol
.
2018 May;199(5):1353-1354.
doi: 10.1016/j.juro.2017.11.138.
Epub 2018 Feb 9.
Authors
Laura-Maria Krabbe
1
2
,
Barbara Heitzplatz
3
,
Sina Preuss
1
,
Ryan C. Hutchinson
2
,
Solomon L. Woldu
2
,
Nirmish Singla
2
,
Martin Boegemann
1
,
Christopher G. Wood
4
,
Jose A. Karam
4
,
Alon Z. Weizer
5
,
Jay D. Raman
6
,
Mesut Remzi
7
,
Nathalie Rioux-Leclercq
8
,
Andrea Haitel
9
,
Leonid M Rapoport
10
,
Peter V. Glybochko
10
,
Marco Roscigno
11
,
Christian Bolenz
12
,
Karim Bensalah
13
,
Arthur I. Sagalowsky
2
,
Shahrokh F. Shariat
7
,
Yair Lotan
2
,
Evanguelos Xylinas
14
,
Vitaly Margulis
2
Affiliations
1
Department of Urology, University of Muenster Medical Center, Muenster, Germany
2
Department of Urology, University of Texas Medical Center, Dallas, TX, USA
3
Department of Pathology, University of Muenster Medical Center, Muenster, Germany
4
Department of Urology, MD Anderson Cancer Center, Houston, TX, USA
5
Department of Urology, University of Michigan Cancer Center, Ann Arbor, MI, USA
6
Division of Urology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA
7
Department of Urology, Medical University of Vienna, Vienna, Austria
8
Department of Pathology, Centre Hospitalier Universitaire de Rennes, Rennes, France
9
Department of Pathology, Medical University Vienna, Vienna, Austria
10
Department of Uronephrology and Reproductive Health, Sechenov First Moscow State Medical University, Moscow, Russia
11
Department of Urology, Ospedali Riuniti of Bergamo, Bergamo, Italy
12
Department of Urology, University of Ulm, Ulm, Germany
13
Department of Urology, Centre Hospitalier Universitaire de Rennes, Rennes, France
14
Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France
PMID:
29428629
PMCID:
PMC7332225
DOI:
10.1016/j.juro.2017.11.138
No abstract available
Publication types
Comment
MeSH terms
B7-H1 Antigen
Carcinoma, Transitional Cell*
Humans
Prognosis
Programmed Cell Death 1 Receptor
Urologic Neoplasms*
Substances
B7-H1 Antigen
Programmed Cell Death 1 Receptor
Grants and funding
T32 CA136515/CA/NCI NIH HHS/United States